Clinical Trial

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-02-02; most recent amendment 2024-08-16.
Trial Details
NCT Number NCT05236348
Lead Sponsor Aktiia SA
Conditions Hypertension, Blood Pressure, Heart Rate
Enrollment 225 participants
Start Date 2022-01-11
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-19